title: [Combined GnRH agonist/hMG therapy and ovarian overstimulation syndrome].
authors.affiliation: Abteilung für Klinische und Experimentelle Endokrinologie, Universitäts-Frauenklinik Hamburg, Eppendorf.
authors.forename: C
authors.initials: C
authors.lastname: Lindner
authors.forename: W
authors.initials: W
authors.lastname: Braendle
authors.forename: V
authors.initials: V
authors.lastname: Lichtenberg
authors.forename: G
authors.initials: G
authors.lastname: Bettendorf
mesh_terms: D002064:Buserelin / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D006801:Humans; D007006:Hypogonadism / Q000628:therapy*; D007247:Infertility, Female / Q000628:therapy*; D008596:Menotropins / Q000008:administration & dosage*; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D017329:Triptorelin Pamoate
chemical_list: D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins; D002064:Buserelin
vernacular_title: Kombinierte GnRH-Agonist/hMG-Therapie und ovarielles Uberstimulations-syndrom.